Temperature & Humidity Mapping for Pharmaceutical & GMP Storage

WHO Technical Report Series No. 961, Annex 9 — and its Technical Supplement, “Temperature mapping of storage areas” — provides the model guidance used worldwide for qualifying pharmaceutical and vaccine storage. It expects a documented study performed before a facility is first used, after any significant modification to the space or its HVAC system, and on a defined requalification interval (commonly every two to three years). The guidance calls for a sensor grid distributed throughout the volume with deliberate placement at worst-case locations, a mapping period long enough to capture normal operational cycles and ambient variation (with a stated minimum), studies under both empty and loaded conditions where relevant, and mapping under worst-case seasonal extremes. It also expects the study to define where permanent monitoring sensors are sited based on the identified hot and cold spots. Femto Scientific writes mapping protocols and reports directly against these Annex 9 expectations.

Warehouse and walk-in cold-room mapping under cGMP uses a three-dimensional grid of calibrated, NIST-traceable data loggers — from dozens to well over 100 depending on floor area and rack height — positioned across the x, y, and z axes with concentrated coverage at worst-case points: adjacent to personnel and dock doors, at the top and bottom of racking, near HVAC supply and return, and along exterior walls and under the roof. The study is run empty and, where required, loaded with product or a simulated load, over a period long enough (typically 72 hours to 7 days) to capture full operational cycles, and includes door-open and power-failure/recovery challenges. Because large spaces are sensitive to outdoor conditions, mapping is performed in worst-case seasonal extremes or repeated in summer and winter. The resulting report documents uniformity, hot and cold spots, excursion recovery, and pass/fail against acceptance criteria for FDA 21 CFR Part 211 and EU GDP/GMP purposes.

Stability chambers are mapped to prove they hold the tight temperature and relative-humidity setpoints that ICH Q1A(R2) defines for stability programs — for example 25 °C/60% RH and 30 °C/65% RH for long-term storage, 40 °C/75% RH for accelerated conditions, and refrigerated (5 °C) or frozen (−20 °C) chambers. Because both parameters matter, calibrated temperature and humidity loggers are distributed throughout the working volume, typically a minimum of 9 to 15 sensors including the corners, center, and near the door and any control/monitoring probe. The study is run empty and loaded, captures the recovery after a defined open-door interval, and documents temperature and humidity uniformity against the ICH tolerances. Chambers are requalified on a periodic interval and after relocation, repair, or setpoint change. A conforming map is a prerequisite before long-term or accelerated stability studies are placed in the chamber.

Temperature mapping is shaped by several complementary guidance documents. The ISPE Good Practice Guide: Controlled Temperature Chamber Mapping and Monitoring is the most widely used industry reference for how to design and execute chamber, cold-room, and warehouse studies. The WHO Technical Report Series No. 961, Annex 9 (and its Technical Supplement on temperature mapping of storage areas) sets expectations for mapping duration, sensor distribution, worst-case placement, and requalification. PDA publishes technical reports on temperature-controlled storage and distribution of medicinal products that inform load configuration and excursion handling. These sit alongside the enforceable regulations and compendial chapters — FDA 21 CFR Part 211, EU GDP/GMP Annex 15, USP <1079> and USP <1118>, and ICH Q1A for stability chambers — that a mapping report is ultimately written to satisfy.

Ambient conditions outside the space change the load on its HVAC or refrigeration system and the heat flow through the building envelope, so a unit that holds specification in mild weather can develop hot spots in peak summer or cold spots in deep winter. This is most pronounced for warehouses, walk-in cold rooms, and any storage against exterior walls, roofs, or loading docks. For this reason ISPE and WHO guidance recommend mapping under worst-case seasonal conditions — in practice, running the study in both summer and winter, or at least during the season that stresses the space most. Seasonal studies confirm the space stays within acceptance criteria year-round and document the true annual worst case, rather than qualifying the equipment only for the conditions that happened to exist on the day of a single study.